SCHEMBL7971050

SCHEMBL7971050

ONC[C@@H]1[C@@H](c2ccccc2)C1(Cl)Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 7/20 0.38
KMT2A Q03164 7/20 0.38
LMNA P02545 3/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
HTR2B P41595 2/20 0.38
NPSR1 Q6W5P4 2/20 0.36
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
RECQL P46063 1/20 0.35
ABCB1 P08183 2/20 0.35
MAPK1 P28482 1/20 0.35
HPGD P15428 1/20 0.35
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971060 1.00 HTT (0.39) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7971053 1.00 HTT (0.39) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7976044 0.79 HTR2A (0.41) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7976045 0.79 HTR2A (0.41) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7976048 0.79 HTR2A (0.41) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7969534 0.78 HTR2A (0.59) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9191563 0.78 HTR2A (0.59) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9191573 0.78 HTR2A (0.59) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL11139872 0.75 HTT (0.42) HTTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8914129 0.70 HTR2A (0.41) HTTCYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291520-B1 INHIBIT THE ENZYME LIPOXYGENASE; TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASES, ALLERGIC CONDITIONS AND CARDIOVASCULAR DISEASES PFIZER 2001-09-18 US disclosed
EP-0559743-B1 NOVEL HYDROXAMIC ACID AND N-HYDROXYUREA DERIVATIVES AND THEIR USE PFIZER (US) 1995-03-08 EP disclosed